347 related articles for article (PubMed ID: 10942945)
1. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone.
Gerlando Q; Barbera V; Ammatuna E; Franco V; Florena AM; Mariani G
Haematologica; 2000 Aug; 85(8):880-1. PubMed ID: 10942945
[No Abstract] [Full Text] [Related]
2. [Doxorubicin and etoposide-besed combination chemotherapy regimen for peripheral T-cell lymphoma].
Zheng W; Zhu J; Xie Y
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):875-6. PubMed ID: 19173838
[No Abstract] [Full Text] [Related]
3. Successful treatment of lymphomatoid granulomatosis using cyclosporin-A after failure of intensive chemotherapy.
Raez LE; Temple JD; Saldana M
Am J Hematol; 1996 Nov; 53(3):192-5. PubMed ID: 8895691
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma.
Alaibac M; Berti E; Pigozzi B; Chiarion V; Aversa S; Marino F; Peserico A
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S121-3. PubMed ID: 15858508
[No Abstract] [Full Text] [Related]
5. Leukaemic presentation of angioimmunoblastic T-cell lymphoma.
Lin KW; Lee YS; Phipps C
Br J Haematol; 2014 Sep; 166(6):808. PubMed ID: 24974735
[No Abstract] [Full Text] [Related]
6. A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis.
De Samblanx H; Verhoef G; Zachée P; Vandenberghe P
Ann Hematol; 2004 Jul; 83(7):455-9. PubMed ID: 15034757
[TBL] [Abstract][Full Text] [Related]
7. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M
Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389
[TBL] [Abstract][Full Text] [Related]
8. [Angio-immunoblastic lymphadenopathy].
Struyf NJ; Verhelst JA; Convens CG; Beelaerts WJ; Mathijs RJ; Mahler C
Ned Tijdschr Geneeskd; 1993 Jul; 137(30):1516-8. PubMed ID: 8366940
[TBL] [Abstract][Full Text] [Related]
9. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
Peng YL; Huang HQ; Lin XB; Xia ZJ; Li YH; Wang W; He YJ; Pan ZH; Jiang WQ; Guan ZZ
Ai Zheng; 2004 Aug; 23(8):943-6. PubMed ID: 15301720
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features and prognostic factors of angioimmunoblastic T cell lymphoma].
Qin Y; Shi YK; He XH; Yang JL; Zhang CG; Zhou SY; Liu XF; Liu P; Yang S; Zhou LQ; Han XH; Yao JR
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):448-51. PubMed ID: 20819488
[TBL] [Abstract][Full Text] [Related]
11. Angioimmunoblastic lymphadenopathy: an etiology for gastrointestinal lymphomatous polyposis.
Goenka MK; Vaiphei K; Nagi B; Sriram PV; Joshi K; Kochhar R
Am J Gastroenterol; 1996 Jun; 91(6):1236-8. PubMed ID: 8651178
[TBL] [Abstract][Full Text] [Related]
12. Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group.
Siegert W; Agthe A; Griesser H; Schwerdtfeger R; Brittinger G; Engelhard M; Kuse R; Tiemann M; Lennert K; Huhn D
Ann Intern Med; 1992 Sep; 117(5):364-70. PubMed ID: 1380221
[TBL] [Abstract][Full Text] [Related]
13. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H
Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
[TBL] [Abstract][Full Text] [Related]
14. A clinical phase II study of ProMACE-CytaBOM.
Dahlberg S; Miller TP; Fisher RI
J Clin Oncol; 1991 May; 9(5):888. PubMed ID: 1707958
[No Abstract] [Full Text] [Related]
15. Alpha-interferon therapy in advanced unresponsive immunoblastic lymphoma evolved from Waldenström's macroglobulinemia.
Carella AM
Haematologica; 1990; 75(6):581. PubMed ID: 1711503
[No Abstract] [Full Text] [Related]
16. Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
Isogai R; Kawada A; Hashimoto K; Aragane Y; Tezuka T; Maeda Y; Kanamaru A
Dermatology; 2004; 209(3):243-5. PubMed ID: 15459544
[No Abstract] [Full Text] [Related]
17. Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
Gergely L; Aleksza M; Váróczy L; Ponyi A; Sipka S; Illés A; Szegedi G
Eur J Haematol; 2004 May; 72(5):336-41. PubMed ID: 15059068
[TBL] [Abstract][Full Text] [Related]
18. [Angioimmunoblastic T-cell lymphoma accompanied by pure red cell aplasia].
Mizobe T; Tsukada J; Higashi T; Iwashige A; Ota T; Kawano I; Kubota A; Matsuura A; Morimoto H; Ogawa R; Toda Y; Tanaka Y
Rinsho Ketsueki; 2005 Mar; 46(3):211-6. PubMed ID: 16447717
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic syndrome associated with immunoblastic lymphadenopathy-like T-cell lymphoma: simultaneous clinical improvement with chemotherapy.
Anzai T; Hirose W; Nakane H; Kawagoe M; Kawai T; Watanabe K
Jpn J Clin Oncol; 1994 Apr; 24(2):106-10. PubMed ID: 8158857
[TBL] [Abstract][Full Text] [Related]
20. Disseminated strongyloidiasis and cytomegalovirus infection in a patient with anaplastic large cell lymphoma.
Rehman JU; Rao TV; AlKindi S; Dennison D; Pathare AV
Ann Hematol; 2007 Dec; 86(12):925-6. PubMed ID: 17641892
[No Abstract] [Full Text] [Related]
[Next] [New Search]
